1 completed, 1 not yet recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
Follow Mixed Dyslipidemia: new trials by email Literature Review of Mixed Dyslipidemia trials Research Report on Mixed Dyslipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3 Phospholipid Omega-3, Triglyceride Omega-3 - Mixed Dyslipidemia | Not applicable | Not yet recruiting | Fundación del Caribe para la Investigación Biomédica | 105 | 2026-03-01 | 2026-02-10 |
| Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study fenofibrate 160 mg and placebo, simvastatin 20 mg and placebo, fenofibrate 160 mg and simvastatin 20 mg - Type II Diabetes Mellitus, Mixed Dyslipidemia | Not applicable | Completed | Intermountain Health Care, Inc. | 300 | 2002-08-01 | 2008-08-21 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Hypercholesterolemia (1)
Dyslipidemias (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperlipidemias (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Fenofibrate (1) · Simvastatin (1)
Fundación del Caribe para la Investigación Biomédica (1) · Intermountain Health Care, Inc. (1)
Colombia (1) · United States (1)